Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #58
- Final score
- 67.83
- Years on list
- 7
↘ Down 47 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 47 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 33 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 352 since 2021
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | MRK | PFE | VTRS |
|---|---|---|---|
| Climate Change | 75.3 | 82.3 | 81.8 |
| Employee Relations | 61.2 | 64.6 | 56.0 |
| Environment | 64.0 | 67.7 | 71.3 |
| Stakeholders & Society | 69.6 | 67.1 | 75.5 |
| Human Rights | 76.1 | 64.3 | 51.2 |
| Governance | 57.5 | 62.9 | 55.0 |
| Performance Rating | 73.1 | 74.4 | 70.2 |